Revaccination with mRNA-1345 against RSV at 12 months was noninferior to primary vaccination among adults aged 50 years and older.

Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the ...

The 2025–26 respiratory syncytial virus (RSV) season is shaping up to be a pivotal moment in the fight against this significant global health threat. In just the past 2 years, three products have been ...

As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid ...

Respiratory syncytial virus (RSV) is a common respiratory virus which disproportionally affects new-borns and infants.

More severe symptoms of RSV include rapid breathing, difficulty breathing such as babies flaring their nostrils, ribs sucking ...

RSV is a common, contagious, and potentially serious respiratory illness that typically circulates in the fall and ...

As we head deeper into fall and toward the holiday season, your little one may start to exhibit symptoms like a runny nose, cough, or fever. But with the overlap between the common cold, influenza ...

Last year, a group of researchers won the 2024 Ig Nobel Prize in Physiology for discovering that many mammals are capable of breathing through their anus. But as with many Ig Nobel awards, there is a ...

This video is part of “Innovations In: RSV," an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. Zachary Rubin: Holy cow, folks. We’re ...